Conditions
Conditions
- Cancer prevention
- Cancer treatment
- Lung cancer
- Breast cancer
- Leukemia
- Autoimmune diseases
- Type 1 diabetes
- Lupus
- Multiple Sclerosis
- Crohn's disease
- Inflammatory conditions
- Inflammatory bowel disease
- Chronic Obstructive Pulmonary Disease
- Emphysema
- Chronic bronchitis
- Infectious diseases
- Hepatitis B and C
- HIV
- Neurological disorders
- Traumatic brain injury
- Parkinson's disease
- Spinal Cord Injury
- Autism
- Skin and soft tissue conditions
- Anti-Aging
- Burns and wounds
- Skin ulcers
- Acne scars
- Hair loss
- Psoriasis
- Eczema
- Vitiligo
- Hyperpigmentation
- Metabolic disorders
- Obesity
- Diabetes Type 2
- Eye disorders
- Macular degeneration
- Retinal diseases
- Organ damage
- Liver cirrhosis
- Chronic Kidney Disease
- Renal failure
- Limb ischemia
- Chronic pain syndromes
- Fibromyalgia
- Chronic headaches
- Inherited disorders
- Muscular dystrophy
- Cystic Fibrosis
- Psychiatric conditions
- Depression
- Anxiety disorders
- Reproductive health
- Male and female infertility
- Erectile dysfunction
- Menopause
Inflammatory bowel disease
Inflammatory Bowel Disease casts a profound impact on individuals, disrupting their quality of life. Traditional treatments often provide limited success, and the side effects of medications can lead to a cycle of additional drugs for symptom management. Unfortunately, these conventional approaches may fall short in delivering the desired relief for those with Inflammatory Bowel Disease.
Exploring Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease
Recent scientific advancements have shown promise in the efficacy of MSC therapy for addressing inflammatory diseases like Inflammatory Bowel Disease. MSCs exhibit a notable ability to modulate both local and systemic innate and adaptive immune responses. This modulation occurs through the release of various mediators, including immunosuppressive molecules, growth factors, exosomes, chemokines, complement components, and various metabolites.
Building on this foundation, studies confirm the effectiveness of MSCs in treating various manifestations of Inflammatory Bowel Disease. Results suggest significant symptom alleviation and healing, offering hope for those navigating the complexities of this challenging condition.
Protocol
Intravenous transplantation of cord tissue-derived Mesenchymal Stem Cells. This minimally invasive procedure takes approximately 45 minutes and boasts minimal downtime. Most patients can return home just two days after their scheduled appointment.